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WhaT is epiGeneTics?
The term “epigenetics” was coined by Conrad Waddington 
to describe “the branch of biology which studies the caus-
al interactions between genes and their products, which 
bring the phenotype into being” (Goldberg et al., 2007). 
Very broadly, the word has come to refer to the study of 
the regulation of genes, their expression, and how that 
translates into particular phenotypes, independent of any 
change to the underlying DNA sequence. More simply 
stated, epigenetics is the study of functionally relevant 
changes in gene expression (with subsequent changes in 
cellular phenotype) that result from mechanisms other 
than from changes in the underlying DNA nucleotide 
sequence.  
Despite the fact that there is no change in the nucleo tide 
sequence, epigenetic modifications may be heritable and 
can be passed down to subsequent generations through 
cell replication and division of alternative chromatin states. 
This “turning on or off” of genes explains why, despite hav-
ing the same underlying DNA sequence, a keratinocyte 
looks and behaves so differently than a hepatocyte and 
why the epigenetic state is carried over to maintain cell- 
and tissue-type specification. Although a given cell’s (or 
individual’s) genome remains relatively stable over time, 
the epigenome can and does vary depending on a number 
of factors, including environmental conditions. These pro-
cesses allow for many “good” functions, including normal 
organism development; however, aberrant epigenetic 
mechanisms are implicated in different disease processes, 
including malignancies.
This article provides a brief overview of the field of 
epigenetics and offers a glimpse into some of the major 
techniques used to study it, with a particular focus on 
chromatin immunoprecipitation followed by sequencing 
(ChIP-seq), the current standard method for studying 
proteins and other epigenetic factors that bind to DNA.
At the heart of epigenetic control is the organiza-
tion of DNA into chromatin. This begins with 147 base 
pairs of DNA wrapped around eight histone proteins, 
which include the core histones H2A, H2B, H3, and H4 
(Figure 1). Each of these histone octamers is referred to 
as a nucleosome. The nucleosomes are packaged tightly 
into even more compact fibers known as chromatin. 
Through this complex structure, epigenetic regulation 
occurs primarily through four mechanisms. First, DNA 
can undergo direct chemical modification by cytosine 
methylation, which is a general marker of gene silencing. 
Second, posttranslational modifications of the core his-
tones can occur, primarily through methylation, acetyla-
tion, ubiquitylation, and phosphorylation, making up the 
primary chromatin structure (Figure 1). Acting in concert 
with these two aspects of the epigenetic machinery, non-
coding RNAs contribute to the regulation of these pro-
cesses (Greer and Shi, 2012). Finally, the chromatin is then 
packaged, via long-range interactions, into a higher-order 
structure within the cell nucleus. 
All of these organizational steps serve to modulate DNA 
accessibility and thus control gene expression. More open 
regions of chromatin, or euchromatin, are poised for acti-
vation by the transcriptional machinery, whereas more 
ADVANTAGES OF CHIP-SEQ
•  ChIP-seq provides a powerful tool with which to 
assess with excellent resolution the binding of 
any transcription factor, histone modification, or 
other DNA-binding protein of interest across the 
entire genome.
•  It allows investigators to assess how these 
modifications or transcription factors affect 
different phenotypes or disease states. 
LIMITATIONS 
•  ChIP-seq reports only relative, not absolute, 
values of the bound proteins.
•  Investigators must know the factor of interest  
in advance.
•  ChIP-seq can be limited by the availability 
and quality of the antibody to the protein or 
modification of interest.
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are sometimes referred to as the histone code or—more 
accurately, because of the complexity of the histone modi-
fications—as a histone language (Berger, 2007).
Each step of this organization may provide sophisticated 
layers of regulation with potentially profound implications 
ranging from the maintenance of cell fate during cellular 
differentiation in development to the turning on or off of 
tumor suppressors or oncogenes in cancer. For example, 
hypermethylation of the FAS gene decreases its expression 
and results in a reduced ability to undergo apoptosis in 
Sézary syndrome (Jones et al., 2010). That epigenetic fac-
tors may be modifiable or reversible makes their study 
particularly promising from a disease perspective. The 
histone deacetylase inhibitors vorinostat and romidepsin 
used in the treatment of cutaneous T-cell lymphoma are 
two primary examples, and numerous other compounds 
are currently under development (Dummer et al., 2012).
chip Basics
Several techniques are used in genome-wide epigenetic 
studies. ChIP, in which an antibody to a specific histone 
modification or other DNA-binding protein of interest 
is used, lies at the heart of many of these technologies. 
Initially, ChIP was employed to analyze chromatin struc-
ture at discrete genomic loci. It has been used more 
recently in conjunction with microarrays to analyze 
gene expression (ChIP-chip). However, with the advent 
of next-generation sequencing technology and its contin-
uously declining costs, ChIP-seq has become the standard 
method of analyzing genome-wide maps of DNA-binding 
proteins and chromatin modification enrichment.
Offering much greater resolution and depth of coverage, 
ChIP-seq has enabled tremendous progress beyond ChIP-
chip. This comprehensive mapping strategy has allowed 
investigators to ascribe associations between particular his-
tone modifications and either active or repressed transcrip-
tion, as well as assign them to particular locations across 
the genome, including enhancers, promoters, gene bodies, 
and insulators. Numerous variations on the standard ChIP 
closed regions generally exist as more stably repressed 
regions known as constitutive heterochromatin, or regions 
that are repressed but poised for activation, known as fac-
ultative heterochromatin. Certain histone modifications 
tend to be associated with particular transcriptional states, 
such as trimethylation of the histone H3 at lysine number 
4 (H3K4me3) with transcriptionally active euchromatin, 
trimethylation of histone H3 at lysine 9 (H3K9me3) with 
transcriptionally repressed constitutive heterochromatic 
domains, and trimethylation of histone H3 at lysine 27 
(H3K27me3) with facultative heterochromatin. Acetylated 
histones tend to mark active genes. These associations 
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Figure 1. major epigenetic modifications. (a) Histone modification. A 
total of 147 base pairs of DNA (depicted as yellow lines) wrap around eight 
histone proteins (depicted as blue cylinders) to form nucleosomes. When 
nucleosomes are packaged together, they form chromatin. Posttranslational 
modifications (e.g., addition of acetyl, methyl, or ubiquitin groups) of histones 
alter local chromatin conformation. Variability in chromatin compaction 
affects the accessibility of genes. Loosely condensed regions (euchromatin) are 
more actively expressed and tightly condensed regions (heterochromatin) are 
repressed. The image depicts histone acetylation, associated with loosening 
of local chromatin and more active gene expression. (b) DNA methylation. 
DNA methylation occurs through the addition of a methyl group to the C5 
position of cytosine to form 5-methylcytosine, typically at cytosine phosphate 
guanine dinucleotides. In promoter regions, DNA methylation silences genes 
by interfering with transcription factor binding. DNA methylation is typically 
associated with tightly condensed chromatin. Reprinted with permission from 
Cheng and Cho, 2012.
Table 1. chip-seq variations
Technique Basic overview
DNase-seq Uses DNase1 endonuclease to digest the DNA in areas depleted of nucleosomes, thus identifying areas genome 
wide of open chromatin where regulatory factors typically bind, although it does not identify the specific bound 
factors. 
ChIP-exo Uses λ-phage endonuclease digestion of the DNA rather than sonication to greatly improve the resolution of pre-
cisely where the factor of interest binds and to remove contaminating DNA.
FAIRE-seq Formaldehyde-assisted identification of regulatory elements is similar to DNase-seq in that the formaldehyde identi-
fies nucleosome-depleted regulatory regions by extracting the DNA that is not cross-linked to nucleosomes. 
ChIP-MNase Micrococcal nuclease is used to digest the DNA and determine where nucleosomes are present. 
Chromatin-capture technologies  
(3C, 5C, HiC)
These techniques help map higher-order chromatin structure. 3C, or chromosome conformation capture, is a 
method to map local chromosome interactions based on the increased frequency of molecular interactions between 
chromosome fragments in close three-dimensional proximity in the nucleus. 5C extends the amount of the genome 
that can be assayed and HiC allows the entire genome to be assayed, although at a limited resolution.
ChIA-PET (Chromatin interaction analysis with paired-end tag sequencing.) This technique is similar to the chromatin capture 
technologies above, but it employs a chromatin immunoprecipitation step to show how higher-order chromatin 
structure affects transcription.
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protocol have created complementary assays that have 
enhanced our ability to interrogate chromatin modifica-
tions and gain different information (Table 1). 
The initial step in ChIP-seq involves cross-linking DNA 
and protein in a population of cells with formaldehyde. 
The chromatin is then sonicated into small fragments of 
roughly 200–600 base pairs. An antibody to the protein 
or histone modification of interest is used to immunopre-
cipitate the DNA–protein complex. Input DNA (the part of 
the sample that is removed prior to the immunoprecipita-
tion step) is the most common control. The cross-links are 
then reversed to allow the DNA to be assayed by creat-
ing a DNA library for next-generation sequencing. During 
library preparation, the DNA is selected for its size by gel 
electrophoresis, typically in the range of 200–300 base 
pairs. The DNA is then amplified by polymerase chain 
reaction prior to sequencing (Furey, 2012; Park, 2009). 
Most ChIP-seq experiments have been performed 
with the Illumina Genome Analyzer, and they typically 
produce 8–15 million sequence reads, which are then 
mapped back to the human genome to look for peaks of 
signal enrichment of statistical significance relative to the 
control. Establishing these peaks is highly dependent on 
threshold settings. Sharp peaks often define transcription 
factor binding sites, whereas broad peaks often represent 
large domains (Figure 2). In general, the more common a 
histone modification is across the genome, the greater the 
number of sequence reads required to accurately map it.
limiTaTiOns
ChIP reports only relative, and not absolute, enrichment 
of particular modifications across the genome; thus, it is 
not always possible to infer biological relevance when sig-
nals are more subtle. The technique is inherently biased 
in that one must know the particular protein or histone 
modification one seeks prior to starting the procedure. 
Similarly, the specificity and sensitivity (i.e., affinity) of the 
polyclonal antibodies used is one of the most important 
determinants of the success of the experiment. Antibodies 
can vary not only from different companies, but also from 
batch to batch (Furey, 2012; Park, 2009). Development of 
monoclonal antibodies for histone modifications is help-
ing to ameliorate these antibody variation issues.
Both underlying genetic and environmental factors can 
influence the underlying chromatin state. Therefore, it is 
important to keep in mind that ChIP captures a particular 
modification at a particular moment in time, and its results 
are limited by the fact that chromatin can have stable dif-
ferences both across varying cell populations and within 
a population of a particular cell type that may be of vari-
able heterogeneity (Zhou et al., 2011). Thus, to make final 
conclusions, the results of multiple ChIP experiments must 
be aligned and compared. Other quality-control measures 
include testing independent antibodies, given the possibil-
ity of nonspecific binding and cross-reactivity of similar 
histone modifications, and RNA interference against the 
enzymes responsible for adding the modifying group or, 
alternatively, mass spectrometry.
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Figure 2. Basic epigenome browser view. This view highlights an ~9-Kb 
segment of the KRT5 gene, with the dark blue rectangles and lines depicting 
the gene structure. Profiled cells are primary cultured neonatal foreskin 
keratinocytes (KCs, top) and fibroblasts (bottom). These KCs express KRT5, 
whereas fibroblasts do not. Starting from the top, there are high levels of 
H3K4me3 histone modification signal (associated with active transcription) at 
the promoter in KCs (depicted in green). In pink, H3K27me3 signal (associated 
with gene repression) shows low levels in KCs. Regions of methylated DNA are 
depicted in brown, with minimal signal in KCs and high levels in fibroblasts. 
Unmethylated DNA is depicted with light blue vertical bars and shows a 
high number of sequencing peaks for KCs compared with a low number for 
fibroblasts. Reprinted with permission from Cheng and Cho, 2012. 
1. heterochromatin refers to:
A.  Actively transcribed regions of DNA to which 
transcription factors actively bind.
B.  The core structure around which 147 base pairs 
of DNA bind.
C.  Constitutively closed and transcriptionally 
repressed areas of genome organization.
D.  Areas of the genome marked by the histone 
modification H3K4me3.
2.  The major role of chip-seq experiments lies in:
A.  The ability to map DNA methylation patterns 
across the genome.
B.  The ability to map the bound histone modifica-
tions and other proteins bound to chromatin 
across the genome.
C.  The ability to analyze gene expression changes 
with changes in chromatin modifications.
D.  The ability to associate single-nucleotide poly-
morphisms with various disease states.
QUESTIONS
Answers are available as supplementary material online  
and at http://www.scilogs.com/jid/.
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The FuTure
ChIP and its variations (discussed in Table 1) are provid-
ing investigators with powerful tools to study the epigenome 
and its role in normal and diseased states. Next-generation 
sequencing technologies have allowed comprehensive 
genome-wide perspectives through both ChIP-seq and its 
variations (Table 1), as well as other techniques such as 
whole-genome bisulfite sequencing for the study of DNA 
methylation. These techniques are likely to become more 
common and streamlined as sequencing technology continues 
to improve—for example, as sensitive and fast techniques such 
as nanopore sequencing become available. Many important 
questions remain, from how epigenetic marks are inherited 
to dissecting precisely how various epigenetic modifications 
and global changes in chromatin organization are regulated by 
various signals, including environmental exposures and devel-
opmental cues. As these mysteries are unraveled, they should 
have important implications for many fundamental processes 
inherent to dermatology, including processes as diverse as hair 
follicle stem-cell differentiation, skin cancer, and skin aging 
(Botchkarev et al., 2012; Cheng and Cho, 2012).
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SUPPLEMENTARY MATERIAL
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